Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatoid Arthritis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatoid Arthritis
    Heavy Birth Weight Doubles Risk of Developing Rheumatoid Arthritis - (DGNews)
    EMEA Recommends Updated Label Warnings for Etoricoxib-Containing Drugs - (DGNews)
    TopAbstracts in Rheumatoid Arthritis 06/26/2008 - (DGNews)
    Etanercept Plus Methotrexate Prevents Joint Damage in Early Active Rheumatoid Arthritis: Presented at EULAR - (DGDispatch)
    Abatacept and Infliximab Improve ACR and LDAS in Methotrexate-Refractory RA Patients - (DGNews)

    News archive

     Recent webcasts/CME - Rheumatoid Arthritis
    • Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
    • Long-Term Data on Abatacept and Rituximab Show Continued Efficacy in Rheumatoid Arthritis
    • Are Rituximab and Abatacept Safe Over the Long Term in Rheumatoid Arthritis?
    • Pathology and Treatment of Rheumatoid Arthritis: The Role of IL-6 in Inflammation and Rheumatoid Arthritis
      Systemic Pathology of Rheumatoid Arthritis

      Webcasts/CME archive

       Recent cases - Rheumatoid Arthritis
        Rheumatoid Nodule of the Thyrohyoid Membrane: A Case Report
        Recurrent Pneumothorax in a Patient with Rheumatoid Arthritis on Leflunomide Treatment: Case Report and Overview of the Literature
        Spontaneous Esophageal Perforation in a Patient with Achalasia Cardia and Rheumatoid Arthritis
        Rheumatoid Arthritis in Thalassemia Intermedia: Coincidence or Association?
        Gamma/Delta T-cell Receptor Type Granular Lymphocyte Proliferative Disorder Associated with Rheumatoid Arthritis

        Cases archive
          




        my personal edition > rheumatoid arthritis > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Atorvastatin Appears to Reduce Arterial Stiffness in Rheumatoid Arthritis Patients: Presented at ACR

        By Jerry Ingram

        ORLANDO, FL -- October 31, 2003 -- Atorvastatin may reduce arterial stiffness, reducing the risk of cardiovascular disease in patients with rheumatoid arthritis (RA), according to Australian researchers. They presented their findings here in a poster session on October 28th at the American College of Rheumatology 67th Annual Scientific Meeting.

        "Our study suggests that this drug, atorvastatin, may reduce the risk of heart disease in patients with rheumatoid arthritis," said lead investigator Sharon Van Doonum, a consultant from Royal Melbourne Hospital, Parkville, Australia. "This drug improved vascular stiffness, which is possible a surrogate marker of cardiovascular disease. So, the idea is that perhaps this drug can reduce the risk of heart disease in rheumatoid arthritis patients."

        For this investigation, researchers enrolled 30 patients with rheumatoid arthritis, evaluating them before and after 6 weeks of treatment with oral atorvastatin 20 mg daily. They included patients with both normal and elevated LDL cholesterol levels and measured fasting lipids, ESR, CRP and arterial stiffness, which was noted as an augmentation index (AIx).

        The research team found that the augmentation index in their RA patients improved from 34.1±11.4% to 30.7±11% (p<0.0001) after 6 weeks of treatment with atorvastatin. They also noted that fasting LDL cholesterol improved from 3.4±0.8 mmol/L to 1.8±0.5 mmol/L (p<0.0001) with no significant change in blood pressure, pulse rate, CRP or ESR during the study.

        They concluded that treatment with atorvastatin significantly reduced arterial stiffness in patients with RA but did not reduce serum CRP, suggesting a possible role for statins in the prevention of cardiovascular disease in RA patients.


        [Study title: Atorvastatin Reduces Arterial Stiffness in Rheumatoid Arthritis Patients. Presentation 758; Poster 153]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send